140 related articles for article (PubMed ID: 35504427)
21. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
Kuo YC; Rajesh R
Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
23. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticle transport across in vitro olfactory cell monolayers.
Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
[TBL] [Abstract][Full Text] [Related]
25. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
26. PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?
Mante A; Heider M; Zlomke C; Mäder K
Eur J Pharm Biopharm; 2016 Nov; 108():32-40. PubMed ID: 27553262
[TBL] [Abstract][Full Text] [Related]
27. Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo.
Kolter M; Ott M; Hauer C; Reimold I; Fricker G
J Control Release; 2015 Jan; 197():165-79. PubMed ID: 25445700
[TBL] [Abstract][Full Text] [Related]
28. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Hartl N; Adams F; Merkel OM
Adv Ther (Weinh); 2021 Jan; 4(1):. PubMed ID: 33542947
[TBL] [Abstract][Full Text] [Related]
29. Dynamic tracing using ultra-bright labeling and multi-photon microscopy identifies endothelial uptake of poloxamer 188 coated poly(lactic-co-glycolic acid) nano-carriers in vivo.
Khalin I; Severi C; Heimburger D; Wehn A; Hellal F; Reisch A; Klymchenko AS; Plesnila N
Nanomedicine; 2022 Feb; 40():102511. PubMed ID: 34915181
[TBL] [Abstract][Full Text] [Related]
30. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.
Chang J; Jallouli Y; Kroubi M; Yuan XB; Feng W; Kang CS; Pu PY; Betbeder D
Int J Pharm; 2009 Sep; 379(2):285-92. PubMed ID: 19416749
[TBL] [Abstract][Full Text] [Related]
31. Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.
Onyema HN; Berger M; Musyanovych A; Bantz C; Maskos M; Freese C
Biointerphases; 2021 Mar; 16(2):021004. PubMed ID: 33765771
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury.
Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J
Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330
[TBL] [Abstract][Full Text] [Related]
34. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization.
Zhang E; Zhukova V; Semyonkin A; Osipova N; Malinovskaya Y; Maksimenko O; Chernikov V; Sokolov M; Grigartzik L; Sabel BA; Gelperina S; Henrich-Noack P
Eur J Pharm Biopharm; 2020 May; 150():131-142. PubMed ID: 32151727
[TBL] [Abstract][Full Text] [Related]
35. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
36. Endocytosis-like uptake of surface-modified drug nanocarriers into giant unilamellar vesicles.
Tahara K; Tadokoro S; Kawashima Y; Hirashima N
Langmuir; 2012 May; 28(18):7114-8. PubMed ID: 22515197
[TBL] [Abstract][Full Text] [Related]
37. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier.
Kulkarni SA; Feng SS
Nanomedicine (Lond); 2011 Feb; 6(2):377-94. PubMed ID: 21385139
[TBL] [Abstract][Full Text] [Related]
38. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons.
Kuo YC; Tsai HC
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():445-457. PubMed ID: 30033276
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
[TBL] [Abstract][Full Text] [Related]
40. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
